Pfizer (NYSE:PFE) announced positive outcomes from the Phase 3 VERITAC-2 clinical trial, showing vepdegestrant's promise in ...

Shortly after Starboard Value pitched four nominees for Kenvue's | Activist investor Starboard Value proposed four additions ...

SKILLMAN, N.J. Kenvue Inc. (NYSE: KVUE), the world’s largest pure-play consumer health company by revenue, today announced the appointment of two new independent directors, Sara ...

Starboard Value LP underperformed peers in 2024, a year in which Jeff Smith’s activist firm was frustrated with large ...

Philadelphia, Pennsylvania--(Newsfile Corp. - February 26, 2025) - Berger Montague advises shareholders of Pfizer Inc. ("Pfizer" or the "Company") (NYSE: PFE) about an investigation into Pfizer's ...

Following the decline of Pfizer Inc. (NYSE:PFE)'s shareholding in Haleon to below 10%, Bryan Supran, who served as a Non-Executive Director representing Pfizer, resigned from his position on the Board ...

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief medical officer, bringing back an industry veteran to lead its regulatory ...

Pfizer shares jumped 8.6 per cent in Monday's trade on BSE, logging an intraday high at Rs 4,448.35 per share. The stock gained after the company's board approved entering into a marketing and supply ...

KUALA LUMPUR: Malaysia Aviation Group (MAG) and the Singapore Tourism Board (STB) have renewed their strategic partnership to increase travel from Malaysia to Singapore. In a statement today ...

PHILADELPHIA, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Berger Montague advises shareholders of Pfizer Inc. (“Pfizer” or the “Company”) (NYSE: PFE) about an investigation into Pfizer’s Board of ...

New Delhi: Pfizer on Friday said its board has approved signing a marketing and supply agreement with Mylan Pharmaceuticals for two of its brands – Ativan and Pacitane. Ativan is used for the ...